Determination of the frequency of β-lactamase genes (bla SHV, bla TEM, bla CTX-M) and phylogenetic groups among ESBL-producing uropathogenic Escherichia coli isolated from outpatients

Ugly bugs in healthy guts! Carriage of multidrug-resistant and ESBL-producing commensal Enterobacteriaceae in the intestine of healthy Nepalese adults

(2018) Anjila Maharjan et al.   Infection and Drug Resistance

Antimicrobial Resistance and Molecular Epidemiology of ESBL-Producing Escherichia coli Isolated from Outpatients in Town Hospitals of Shandong Province, China

(2017) Zengmin Miao et al.   Frontiers in Microbiology

The prevalence of ESBL-producing Enterobacteriaceae in a nursing home setting compared with elderly living at home: a cross-sectional comparison

(2016) Andreas Blom et al.   BMC INFECTIOUS DISEASES

Antimicrobial Resistance in Community-AcquiredEscherichia coliIsolated from Urinary Infection: Good News or Bad?

(2016) Lindsay E Nicolle   Canadian Journal of Infectious Diseases & Medical Microbiology

Virulence, serotype and phylogenetic groups of diarrhoeagenic Escherichia coli isolated during digestive infections in Abidjan, Cte dIvoire

(2014) Dadie Adjhi et al.   AFRICAN JOURNAL OF BIOTECHNOLOGY

TheEscherichia coliphylogenetic group B2 with integrons prevails in childhood recurrent urinary tract infections

(2013) Siiri Kõljalg et al.   APMIS

Composition of Escherichia coli population in the neonatal gut: phylogroups and virulence determinants

(2013) P. Das et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Similarity and Divergence of Phylogenies, Antimicrobial Susceptibilities, and Virulence Factor Profiles of Escherichia coli Isolates Causing Recurrent Urinary Tract Infections That Persist or Result from Reinfection

(2012) Y. Luo et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Virulence profile of different phylogenetic groups of locally isolated community acquired uropathogenic E. coli from Faisalabad region of Pakistan

(2012) Saira Bashir et al.   Annals of Clinical Microbiology and Antimicrobials

Epidemiology and Risk Factors of Community Onset Infections Caused by Extended-Spectrum  -Lactamase-Producing Escherichia coli Strains

(2011) C.-I. Kang et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Oral Treatment Options for Ambulatory Patients with Urinary Tract Infections Caused by Extended-Spectrum- -Lactamase-Producing Escherichia coli

(2010) S. Auer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impact

(2010) Jesús Oteo et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum β-lactamase-producing Escherichia coli

(2010) Cheol-In Kang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The epidemiology of urinary tract infection

(2010) Betsy Foxman   Nature Reviews Urology

A Multinational Survey of Risk Factors for Infection with Extended‐Spectrum β‐Lactamase–Producing Enterobacteriaceae in Nonhospitalized Patients

(2009) Ronen Ben‐Ami et al.   CLINICAL INFECTIOUS DISEASES

Nationwide survey of extended-spectrum β-lactamase-producing Enterobacteriaceae in the French community setting

(2009) C. Arpin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Relationship of drug resistance to phylogenetic groups of E. coli isolates from wound infections

(2009) Abdul Haque et al.   Journal of Infection in Developing Countries

Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli

(2008) Jesús Rodríguez-Baño et al.   ARCHIVES OF INTERNAL MEDICINE

Complicated Catheter-Associated Urinary Tract Infections Due to Escherichia coli and Proteus mirabilis

(2008) S. M. Jacobsen et al.   CLINICAL MICROBIOLOGY REVIEWS